# Eric D. Jacobsen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/eric-d-jacobsen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 18,893 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 54 |
| i10-index | 125 |
| Last Known Institution | Dana-Farber Cancer Institute |
| OpenAlex ID | https://openalex.org/A5083104525 |
| ORCID iD | https://orcid.org/0000-0003-3014-0023 |
| Works | 358 |

## Researcher papers

- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease](https://scholariq.org/papers/consensus-recommendations-for-the-diagnosis-and-clinical-management-of-rosai/)
- [The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice](https://scholariq.org/papers/the-public-repository-of-xenografts-enables-discovery-and-randomized-phase-ii/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Cutaneous lymphoproliferative disorders research](https://scholariq.org/topics/cutaneous-lymphoproliferative-disorders-research/)
- [T-cell and Retrovirus Studies](https://scholariq.org/topics/t-cell-and-retrovirus-studies/)

## Researcher university

- [Dana-Farber Cancer Institute](https://scholariq.org/institutions/dana-farber-cancer-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.